NORTHERN TRUST CORP - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 63 filers reported holding CUE BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$755,976
-37.5%
328,685
-0.8%
0.00%
Q2 2023$1,209,738
+332.8%
331,435
+323.3%
0.00%
Q1 2023$279,531
+56.7%
78,300
+25.1%
0.00%
Q4 2022$178,379
+28.3%
62,5890.0%0.00%
Q3 2022$139,000
-7.3%
62,589
+3.5%
0.00%
Q2 2022$150,000
-89.9%
60,474
-80.1%
0.00%
Q1 2022$1,486,000
-58.5%
304,346
-3.8%
0.00%
-100.0%
Q4 2021$3,579,000
-20.7%
316,467
+2.2%
0.00%0.0%
Q3 2021$4,513,000
+21.3%
309,770
-3.0%
0.00%0.0%
Q2 2021$3,721,000
-7.8%
319,315
-3.4%
0.00%0.0%
Q1 2021$4,035,000
-6.2%
330,694
-3.8%
0.00%0.0%
Q4 2020$4,300,000
-17.8%
343,745
-1.1%
0.00%0.0%
Q3 2020$5,230,000
-39.2%
347,532
-1.0%
0.00%
-50.0%
Q2 2020$8,608,000
+156.6%
351,218
+48.5%
0.00%
+100.0%
Q1 2020$3,355,000
-4.0%
236,474
+7.5%
0.00%0.0%
Q4 2019$3,493,000
+85.2%
220,073
-1.6%
0.00%
Q3 2019$1,886,000
+2.6%
223,652
+9.3%
0.00%
Q2 2019$1,839,000
+18.6%
204,555
+2.0%
0.00%
Q1 2019$1,551,000
+74.1%
200,585
+5.8%
0.00%
Q4 2018$891,000
-48.4%
189,572
-0.7%
0.00%
Q3 2018$1,728,000
-19.3%
190,973
+5.8%
0.00%
-100.0%
Q2 2018$2,141,000
+102.7%
180,486
+140.2%
0.00%
Q1 2018$1,056,00075,1530.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
Prosight Management, LP 1,545,573$3,447,0001.85%
P.A.W. CAPITAL CORP 200,000$446,0000.67%
SANDERS MORRIS HARRIS LLC 848,048$2,020,0000.50%
Monaco Asset Management SAM 458,851$1,023,0000.39%
Bleichroeder LP 555,000$1,238,0000.26%
APOGEM CAPITAL LLC 110,614$247,0000.25%
Slate Path Capital LP 1,483,619$3,308,0000.22%
Voss Capital, LLC 200,000$446,0000.13%
Robertson Stephens Wealth Management, LLC 478,500$1,067,0000.11%
CARLSON CAPITAL L P 535,000$1,193,0000.09%
View complete list of CUE BIOPHARMA INC shareholders